|Soraprazan is a reversible and fast-acting inhibitor of gastric H+/K+ ATPase.
|SKF96067 is a reversible inhibitor of the gastric H+/K+-ATPase.
|SCH 28080 is an inhibitor of H+, K+-ATPase with IC50 of 20 nM.
|Picoprazole is a selective inhibitor of H+/K+-ATPase with IC50 of 3.1 ± 0.4 μM.
|PF 03716556 is a selective HK ATPase inhibitor with pIC50 value of 6009
|KM91104 is a specific v-ATPase inhibitor. It specifically targets the interaction between v-ATPase subunit a3 and subunit B2.
|Ilaprazole inhibited TOPK activities with high affinity and selectivity.
|FCCP is a potent uncoupler of oxidative phosphorylation in mitochondria that disrupts ATP synthesis by transporting protons across cell membranes
|Esomeprazole is a proton-pump inhibitor which reduces stomach acid
|EN6 covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal the vacuolar H+ ATPase (v-ATPase). It is a small-molecule in vivo activator of autophagy.
|Citreoviridin is a mycotoxin isolated from several Penicillium species that has been shown to inhibit the mitochondrial ATP synthetase system.
|Ciclopirox Olamine is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses
|CDN1163 is an allosteric sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator that improves Ca2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders.
|BTB06584 is an IF1-dependent selective inhibitor of the mitochondrial F1Fo-ATPase
|BHQ is a selective inhibitor of sarco-endoplasmic reticulum Ca2-ATPase SERCA
|AZD0865 inhibits gastric HK-ATPase by K-competitive binding
|--Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of 2 M in cell-free assays does not inhibit myosin light chain kinase inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly